A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protoc (Q41556432)
Jump to navigation
Jump to search
scientific article published on 29 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protoc |
scientific article published on 29 August 2017 |
Statements
1 reference
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protoc (English)
1 reference
David Cunningham
1 reference
Nick J Battersby
1 reference
Mit Dattani
1 reference
Sheela Rao
1 reference
Diana Tait
1 reference
Brendan J Moran
1 reference
Shelize Khakoo
1 reference
Paris Tekkis
1 reference
Shahnawaz Rasheed
1 reference
Alex Mirnezami
1 reference
Nicholas P West
1 reference
Iris Nagtegaal
1 reference
Irene Chong
1 reference
Michelle Frost
1 reference
Gina Brown
1 reference
29 August 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference